Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 6269157, 15 pages
http://dx.doi.org/10.1155/2016/6269157
Review Article

Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells

Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA

Received 23 October 2015; Revised 15 January 2016; Accepted 7 February 2016

Academic Editor: Christine Trumpfheller

Copyright © 2016 Xiaofeng Liao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Tsokos, “Systemic lupus erythematosus,” The New England Journal of Medicine, vol. 365, no. 22, pp. 2110–2121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. G. K. W. Lam and M. Petri, “Assessment of systemic lupus erythematosus,” Clinical and Experimental Rheumatology, vol. 23, no. 5, supplement 39, pp. S120–S132, 2005. View at Google Scholar · View at Scopus
  3. M. J. Shlomchik, J. E. Craft, and M. J. Mamula, “From T to B and back again: positive feedback in systemic autoimmune disease,” Nature Reviews Immunology, vol. 1, no. 2, pp. 147–153, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. Liu and A. Davidson, “Taming lupus-a new understanding of pathogenesis is leading to clinical advances,” Nature Medicine, vol. 18, no. 6, pp. 871–882, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Rahman and D. A. Isenberg, “Systemic lupus erythematosus,” The New England Journal of Medicine, vol. 358, no. 9, pp. 929–939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. T. K. Nowling and G. S. Gilkeson, “Mechanisms of tissue injury in lupus nephritis,” Arthritis Research & Therapy, vol. 13, no. 6, article 250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Inaba and R. M. Steinman, “Protein-specific helper T-lymphocyte formation initiated by dendritic cells,” Science, vol. 229, no. 4712, pp. 475–479, 1985. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Merad, P. Sathe, J. Helft, J. Miller, and A. Mortha, “The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting,” Annual Review of Immunology, vol. 31, pp. 563–604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. N. Theofilopoulos, R. Baccala, B. Beutler, and D. H. Kono, “Type I interferons (α/β) in immunity and autoimmunity,” Annual Review of Immunology, vol. 23, pp. 307–336, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Grouard, M.-C. Rissoan, L. Filgueira, I. Durand, J. Banchereau, and Y.-J. Liu, “The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand,” Journal of Experimental Medicine, vol. 185, no. 6, pp. 1101–1111, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Ganguly, S. Haak, V. Sisirak, and B. Reizis, “The role of dendritic cells in autoimmunity,” Nature Reviews Immunology, vol. 13, no. 8, pp. 566–577, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Birnberg, L. Bar-On, A. Sapoznikov et al., “Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome,” Immunity, vol. 29, no. 6, pp. 986–997, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Ohnmacht, A. Pullner, S. B. S. King et al., “Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity,” The Journal of Experimental Medicine, vol. 206, no. 3, pp. 549–559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. L. L. Teichmann, M. L. Ols, M. Kashgarian, B. Reizis, D. H. Kaplan, and M. J. Shlomchik, “Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage,” Immunity, vol. 33, no. 6, pp. 967–978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Yan, B. P. Harvey, R. J. Gee, M. J. Shlomchik, and M. J. Mamula, “B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation,” The Journal of Immunology, vol. 177, no. 7, pp. 4481–4487, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. L. Rowland, J. M. Riggs, S. Gilfillan et al., “Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model,” The Journal of Experimental Medicine, vol. 211, no. 10, pp. 1977–1991, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. L. M. Davison and T. N. Jørgensen, “Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice,” Arthritis & Rheumatology, vol. 67, no. 4, pp. 1012–1022, 2015. View at Publisher · View at Google Scholar
  18. J. C. Crispín, M. I. Vargas-Rojas, A. Monsiváis-Urenda, and J. Alcocer-Varela, “Phenotype and function of dendritic cells of patients with systemic lupus erythematosus,” Clinical Immunology, vol. 143, no. 1, pp. 45–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Migita, T. Miyashita, Y. Maeda et al., “Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus,” Clinical and Experimental Immunology, vol. 142, no. 1, pp. 84–91, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Fiore, G. Castellano, A. Blasi et al., “Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis,” Molecular Immunology, vol. 45, no. 1, pp. 259–265, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Jin, S. Kavikondala, L. Sun et al., “Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression,” Lupus, vol. 17, no. 7, pp. 654–662, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. A. Khan, J. Nowatzky, S. Jiménez-Branda et al., “Active systemic lupus erythematosus is associated with decreased blood conventional dendritic cells,” Experimental and Molecular Pathology, vol. 95, no. 2, pp. 121–123, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Henriques, L. Inês, T. Carvalheiro et al., “Functional characterization of peripheral blood dendritic cells and monocytes in systemic lupus erythematosus,” Rheumatology International, vol. 32, no. 4, pp. 863–869, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Segerer, F. Heller, M. T. Lindenmeyer et al., “Compartment specific expression of dendritic cell markers in human glomerulonephritis,” Kidney International, vol. 74, no. 1, pp. 37–46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Schiffer, R. Bethunaickan, M. Ramanujam et al., “Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis,” The Journal of Immunology, vol. 180, no. 3, pp. 1938–1947, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Bethunaickan, C. C. Berthier, M. Ramanujam et al., “A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis,” The Journal of Immunology, vol. 186, no. 8, pp. 4994–5003, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Sahu, R. Bethunaickan, S. Singh, and A. Davidson, “Structure and function of renal macrophages and dendritic cells from lupus-prone mice,” Arthritis and Rheumatology, vol. 66, no. 6, pp. 1596–1607, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Liao, J. Ren, C. H. Wei et al., “Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model,” PLoS ONE, vol. 10, no. 3, Article ID e0118176, 2015. View at Publisher · View at Google Scholar
  29. J. A. Deane, P. Pisitkun, R. S. Barrett et al., “Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation,” Immunity, vol. 27, no. 5, pp. 801–810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. B. Buechler, T. H. Teal, K. B. Elkon, and J. A. Hamerman, “Cutting edge: type i ifn drives emergency myelopoiesis and peripheral myeloid expansion during chronic tlr7 signaling,” The Journal of Immunology, vol. 190, no. 3, pp. 886–891, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. L. Kalled, A. H. Cutler, and L. C. Burkly, “Apoptosis and altered dendritic cell homeostasis in lupus nephritis are limited by anti-CD154 treatment,” Journal of Immunology, vol. 167, no. 3, pp. 1740–1747, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Clatworthy, C. E. P. Aronin, R. J. Mathews, N. Y. Morgan, K. G. C. Smith, and R. N. Germain, “Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes,” Nature Medicine, vol. 20, no. 12, pp. 1458–1463, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Gonzalvo-Feo, A. Del Prete, M. Pruenster et al., “Endothelial cell-derived chemerin promotes dendritic cell transmigration,” Journal of Immunology, vol. 192, no. 5, pp. 2366–2373, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. G. De Palma, G. Castellano, A. Del Prete et al., “The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritis,” Kidney International, vol. 79, no. 11, pp. 1228–1235, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Rodriguez-Pla, P. Patel, H. T. Maecker et al., “IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes,” Journal of Immunology, vol. 192, no. 12, pp. 5586–5598, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Ding, H. Mehta, W. J. McCune, and M. J. Kaplan, “Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus,” The Journal of Immunology, vol. 177, no. 9, pp. 5878–5889, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Colonna, J.-A. Dinnal, D. K. Shivers, L. Frisoni, R. Caricchio, and S. Gallucci, “Abnormal costimulatory phenotype and function of dendritic cells before and after the onset of severe murine lupus,” Arthritis Research and Therapy, vol. 8, no. 2, article R49, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. M. A. Gleisner, P. Reyes, J. Alfaro et al., “Dendritic and stromal cells from the spleen of lupic mice present phenotypic and functional abnormalities,” Molecular Immunology, vol. 54, no. 3-4, pp. 423–434, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Wan, C. Xia, and L. Morel, “IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions,” Journal of Immunology, vol. 178, no. 1, pp. 271–279, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Berkun, I. Verbovetski, A. Ben-Ami et al., “Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus,” European Journal of Immunology, vol. 38, no. 10, pp. 2896–2904, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. L. J. Carreno, R. Pacheco, M. A. Gutierrez, S. Jacobelli, and A. M. Kalergis, “Disease activity in systemic lupus erythematosus is associated with an altered expression of low-affinity Fcγ receptors and costimulatory molecules on dendritic cells,” Immunology, vol. 128, no. 3, pp. 334–341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Sallusto and A. Lanzavecchia, “Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α,” The Journal of Experimental Medicine, vol. 179, no. 4, pp. 1109–1118, 1994. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Blanco, A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau, “Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus,” Science, vol. 294, no. 5546, pp. 1540–1543, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. G.-M. Deng, L. Liu, V. C. Kyttaris, and G. C. Tsokos, “Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway,” The Journal of Immunology, vol. 184, no. 12, pp. 7154–7161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Joo, C. Coquery, Y. Xue et al., “Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation,” The Journal of Experimental Medicine, vol. 209, no. 7, pp. 1335–1348, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. V. Urbonaviciute, B. G. Fürnrohr, S. Meister et al., “Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE,” The Journal of Experimental Medicine, vol. 205, no. 13, pp. 3007–3018, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. J. H. Fransen, L. B. Hilbrands, J. Ruben et al., “Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17,” Arthritis & Rheumatism, vol. 60, no. 8, pp. 2304–2313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J. H. Fransen, L. B. Hilbrands, C. W. Jacobs, G. J. Adema, J. H. Berden, and J. Van der Vlag, “Both early and late apoptotic blebs are taken up by DC and induce IL-6 production,” Autoimmunity, vol. 42, no. 4, pp. 325–327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Ivanov, A.-M. Dragoi, X. Wang et al., “A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA,” Blood, vol. 110, no. 6, pp. 1970–1981, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Yasuda, C. Richez, M. B. Uccellini et al., “Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes,” Journal of Immunology, vol. 183, no. 5, pp. 3109–3117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Decker, H. Singh-Jasuja, S. Haager, I. Kötter, and H.-G. Rammensee, “Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation,” The Journal of Immunology, vol. 174, no. 6, pp. 3326–3334, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Kis-Toth, A. Szanto, T.-H. Thai, and G. C. Tsokos, “Cytosolic DNA-activated human dendritic cells are potent activators of the adaptive immune response,” The Journal of Immunology, vol. 187, no. 3, pp. 1222–1234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Savarese, O.-W. Chae, S. Trowitzsch et al., “U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7,” Blood, vol. 107, no. 8, pp. 3229–3234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Ganguly, G. Chamilos, R. Lande et al., “Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8,” The Journal of Experimental Medicine, vol. 206, no. 9, pp. 1983–1994, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Vas, C. Grönwall, A. Marshak-Rothstein, and G. J. Silverman, “Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes,” Arthritis and Rheumatism, vol. 64, no. 10, pp. 3388–3398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Gronwall, Y. Chen, J. Vas et al., “MAPK phosphatase-1 is required for regulatory natural autoantibody-mediated inhibition of TLR responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 48, pp. 19745–19750, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. E. V. Clarke, B. M. Weist, C. M. Walsh, and A. J. Tenner, “Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation,” Journal of Leukocyte Biology, vol. 97, no. 1, pp. 147–160, 2015. View at Publisher · View at Google Scholar
  58. B. Desnues, A. B. Macedo, A. Roussel-Queval et al., “TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 4, pp. 1497–1502, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. L. L. Teichmann, D. Schenten, R. Medzhitov, M. Kashgarian, and M. J. Shlomchik, “Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus,” Immunity, vol. 38, no. 3, pp. 528–540, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Lamagna, P. Scapini, J. A. van Ziffle, A. L. DeFranco, and C. A. Lowell, “Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 35, pp. E3311–E3320, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Tada, S. Kondo, S. Aoki et al., “Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice,” Arthritis and Rheumatism, vol. 63, no. 3, pp. 738–748, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Kool, G. van Loo, W. Waelput et al., “The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity,” Immunity, vol. 35, no. 1, pp. 82–96, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. S. J. Kim, P. K. Gregersen, and B. Diamond, “Regulation of dendritic cell activation by microRNA let-7c and BLIMP1,” The Journal of Clinical Investigation, vol. 123, no. 2, pp. 823–833, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. S. J. Kim, Y. R. Zou, J. Goldstein, B. Reizis, and B. Diamond, “Tolerogenic function of Blimp-1 in dendritic cells,” The Journal of Experimental Medicine, vol. 208, no. 11, pp. 2193–2199, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Chen, L. Huang, and J. Wang, “Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity,” Blood, vol. 109, no. 10, pp. 4360–4367, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. B. P. dos Santos, J. V. Valverde, P. Rohr et al., “TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from Southern Brazil,” Lupus, vol. 21, no. 3, pp. 302–309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Kawasaki, C. Kyogoku, J. Ohashi et al., “Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms,” Arthritis & Rheumatism, vol. 58, no. 3, pp. 826–834, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. S. L. Musone, K. E. Taylor, T. T. Lu et al., “Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus,” Nature Genetics, vol. 40, no. 9, pp. 1062–1064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. R. Lu, G. S. Vidal, J. A. Kelly et al., “Genetic associations of LYN with systemic lupus erythematosus,” Genes and Immunity, vol. 10, no. 5, pp. 397–403, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. V. Gateva, J. K. Sandling, G. Hom et al., “A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus,” Nature Genetics, vol. 41, no. 11, pp. 1228–1233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. M. A. Jensen, K. C. Patterson, A. A. Kumar, M. Kumabe, B. S. Franek, and T. B. Niewold, “Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients,” Annals of the Rheumatic Diseases, vol. 72, no. 4, pp. 596–601, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Xie, C. Hua, L. Sun et al., “17β-estradiol induces CD40 expression in dendritic cells via MAPK signaling pathways in a minichromosome maintenance protein 6-dependent manner,” Arthritis & Rheumatism, vol. 63, no. 8, pp. 2425–2435, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. E. Csomor, Z. Bajtay, N. Sándor et al., “Complement protein C1q induces maturation of human dendritic cells,” Molecular Immunology, vol. 44, no. 13, pp. 3389–3397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. B. K. Teh, J. G. Yeo, L. M. Chern, and J. Lu, “C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation,” Molecular Immunology, vol. 48, no. 9-10, pp. 1128–1138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. P. B. Stranges, J. Watson, C. J. Cooper et al., “Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity,” Immunity, vol. 26, no. 5, pp. 629–641, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Chen, K. Felix, and J. Wang, “Immune regulation through mitochondrion-dependent dendritic cell death induced by T regulatory cells,” The Journal of Immunology, vol. 187, no. 11, pp. 5684–5692, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Chen, Y.-H. Wang, Y. Wang et al., “Dendritic cell apoptosis in the maintenance of immune tolerance,” Science, vol. 311, no. 5764, pp. 1160–1164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Yang, B. Li, P. Lv, Y. Zhang, and X.-M. Gao, “Interaction between antigen presenting cells and autoreactive T cells derived from BXSB mice with murine lupus,” Cell Research, vol. 17, no. 6, pp. 556–564, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. T.-C. Tzeng, J.-L. Suen, and B.-L. Chiang, “Dendritic cells pulsed with apoptotic cells activate self-reactive T-cells of lupus mice both in vitro and in vivo,” Rheumatology, vol. 45, no. 10, pp. 1230–1237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. L. Estrada-Capetillo, B. Hernández-Castro, A. Monsiváis-Urenda et al., “Induction of Th17 lymphocytes and treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus,” Clinical and Developmental Immunology, vol. 2013, Article ID 584303, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Wan, Z. Zhou, B. Duan, and L. Morel, “Direct B cell stimulation by dendritic cells in a mouse model of lupus,” Arthritis and Rheumatism, vol. 58, no. 6, pp. 1741–1750, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Sang, Y.-Y. Zheng, Y. Yin et al., “Dysregulated cytokine production by dendritic cells modulates B cell responses in the NZM2410 mouse model of lupus,” PLoS ONE, vol. 9, no. 8, Article ID e102151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. M. M. Gilbert, D. G. Carnathan, P. C. Cogswell, L. Lin, A. S. Baldwin Jr., and B. J. Vilen, “Dendritic cells from lupus-prone mice are defective in repressing immunoglobulin secretion,” The Journal of Immunology, vol. 178, no. 8, pp. 4803–4810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Iwata, K. Furuichi, N. Sakai et al., “Dendritic cells contribute to autoimmune kidney injury in MRL-Faslpr mice,” The Journal of Rheumatology, vol. 36, no. 2, pp. 306–314, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Look, E. Stern, Q. A. Wang et al., “Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice,” The Journal of Clinical Investigation, vol. 123, no. 4, pp. 1741–1749, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Look, W. M. Saltzman, J. Craft, and T. M. Fahmy, “The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus,” Biomaterials, vol. 35, no. 3, pp. 1089–1095, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. Y. Zhang, S. Liu, Y. Yu et al., “Immune complex enhances tolerogenecity of immature dendritic cells via FcγRIIb and promotes FcγRIIb-overexpressing dendritic cells to attenuate lupus,” European Journal of Immunology, vol. 41, no. 4, pp. 1154–1164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. Y. Xia, S. Jiang, S. Weng, X. Lv, H. Cheng, and C. Fang, “Antigen-specific immature dendritic cell vaccine ameliorates anti-dsDNA antibody-induced renal damage in a mouse model,” Rheumatology, vol. 50, no. 12, pp. 2187–2196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. U. Sela, A. Sharabi, M. Dayan, R. Hershkoviz, and E. Mozes, “The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models,” Immunology, vol. 128, no. 1, supplement, pp. e395–e405, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. H. J. Wu, Y. Lo, D. Luk, C. S. Lau, L. Lu, and M. Y. Mok, “Alternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function,” Clinical Immunology, vol. 156, no. 1, pp. 43–57, 2015. View at Publisher · View at Google Scholar · View at Scopus
  91. K. Santana-de Anda, D. Gómez-Martín, A. E. Monsivais-Urenda, M. Salgado-Bustamante, R. González-Amaro, and J. Alcocer-Varela, “Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population,” Clinical and Experimental Immunology, vol. 178, no. 3, pp. 428–437, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. T. Carvalheiro, A. Rodrigues, A. Lopes et al., “Tolerogenic versus inflammatory activity of peripheral blood monocytes and dendritic cells subpopulations in systemic lupus erythematosus,” Clinical and Developmental Immunology, vol. 2012, Article ID 934161, 14 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Blomberg, M.-L. Eloranta, M. Magnusson, G. V. Alm, and L. Ronnblom, “Expression of the markers BDCA-2 and BDCA-4 and production of interferon-α by plasmacytoid dendritic cells in systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 48, no. 9, pp. 2524–2532, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. P. Wu, J. Wu, S. Liu et al., “TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients,” Clinical Immunology, vol. 129, no. 1, pp. 40–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Tucci, C. Quatraro, L. Lombardi, C. Pellegrino, F. Dammacco, and F. Silvestris, “Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18,” Arthritis and Rheumatism, vol. 58, no. 1, pp. 251–262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. W. Vermi, S. Lonardi, M. Morassi et al., “Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage,” Immunobiology, vol. 214, no. 9-10, pp. 877–886, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. Q. Yin, X. Xu, Y. Lin, J. Lv, L. Zhao, and R. He, “Ultraviolet B irradiation induces skin accumulation of plasmacytoid dendritic cells: a possible role for chemerin,” Autoimmunity, vol. 47, no. 3, pp. 185–192, 2014. View at Publisher · View at Google Scholar
  98. J. W. Park, S. Y. Moon, J. H. Lee et al., “Bone marrow analysis of immune cells and apoptosis in patients with systemic lupus erythematosus,” Lupus, vol. 23, no. 10, pp. 975–985, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. T. Ito, H. Kanzler, O. Duramad, W. Cao, and Y.-J. Liu, “Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells,” Blood, vol. 107, no. 6, pp. 2423–2431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. H. Agrawal, N. Jacob, E. Carreras et al., “Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease,” The Journal of Immunology, vol. 183, no. 9, pp. 6021–6029, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. E. Pau, Y.-H. Cheung, C. Loh, G. Lajoie, and J. E. Wither, “TLR tolerance reduces IFN-alpha production despite plasmacytoid dendritic cell expansion and anti-nuclear antibodies in NZB bicongenic mice,” PLoS ONE, vol. 7, no. 5, Article ID e36761, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. Y. Zhan, E. M. Carrington, H. Ko et al., “Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-alpha production,” Arthritis & Rheumatology, vol. 67, no. 3, pp. 797–808, 2015. View at Publisher · View at Google Scholar
  103. C. Guiducci, M. Gong, Z. Xu et al., “TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus,” Nature, vol. 465, no. 7300, pp. 937–941, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. Y. Hong, J. Wu, J. Zhao et al., “miR-29b and miR-29c are involved in Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid dendritic cells,” PLoS ONE, vol. 8, no. 7, Article ID e69926, 2013. View at Publisher · View at Google Scholar · View at Scopus
  105. Y. Lepelletier, R. Zollinger, C. Ghirelli et al., “Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid predendritic cells (pDCs),” Blood, vol. 116, no. 18, pp. 3389–3397, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. I. Bonaccorsi, C. Cantoni, P. Carrega et al., “The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNα production,” PLoS ONE, vol. 5, no. 11, Article ID e15080, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. F. Kanakoudi-Tsakalidou, E. Farmaki, V. Tzimouli et al., “Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE.. New therapeutic options?” Lupus, vol. 23, no. 3, pp. 305–312, 2014. View at Publisher · View at Google Scholar · View at Scopus
  108. G. S. Garcia-Romo, S. Caielli, B. Vega et al., “Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus,” Science Translational Medicine, vol. 3, no. 73, Article ID 73ra20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  109. X. Liao, S. Li, R. E. Settlage et al., “Cutting edge: plasmacytoid dendritic cells in late-stage lupus mice defective in producing IFN-α,” The Journal of Immunology, vol. 195, no. 10, pp. 4578–4582, 2015. View at Publisher · View at Google Scholar
  110. L. E. Wilson, D. Widman, S. H. Dikman, and P. D. Gorevic, “Autoimmune disease complicating antiviral therapy for hepatitis C virus infection,” Seminars in Arthritis and Rheumatism, vol. 32, no. 3, pp. 163–173, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. L. E. Rönnblom, G. V. Alm, and K. E. Öberg, “Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour,” Journal of Internal Medicine, vol. 227, no. 3, pp. 207–210, 1990. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Mathian, A. Weinberg, M. Gallegos, J. Banchereau, and S. Koutouzov, “IFN-α induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice,” Journal of Immunology, vol. 174, no. 5, pp. 2499–2506, 2005. View at Publisher · View at Google Scholar · View at Scopus
  113. M.-L. Santiago-Raber, R. Baccala, K. M. Haraldsson et al., “Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice,” The Journal of Experimental Medicine, vol. 197, no. 6, pp. 777–788, 2003. View at Publisher · View at Google Scholar · View at Scopus
  114. D. Braun, P. Geraldes, and J. Demengeot, “Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice,” Journal of Autoimmunity, vol. 20, no. 1, pp. 15–25, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. J. D. Hron and S. L. Peng, “Type I IFN protects against murine lupus,” The Journal of Immunology, vol. 173, no. 3, pp. 2134–2142, 2004. View at Publisher · View at Google Scholar · View at Scopus
  116. R. Baccala, R. Gonzalez-Quintial, R. D. Schreiber, B. R. Lawson, D. H. Kono, and A. N. Theofilopoulos, “Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed mice,” Journal of Immunology, vol. 189, no. 12, pp. 5976–5984, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. V. Sisirak, D. Ganguly, K. L. Lewis et al., “Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus,” The Journal of Experimental Medicine, vol. 211, no. 10, pp. 1969–1976, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. D. M. Santer, A. E. Wiedeman, T. H. Teal, P. Ghosh, and K. B. Elkon, “Plasmacytoid dendritic cells and C1q differentially regulate inflammatory gene induction by lupus immune complexes,” Journal of Immunology, vol. 188, no. 2, pp. 902–915, 2012. View at Publisher · View at Google Scholar · View at Scopus
  119. E.-M. Fehr, S. Spoerl, P. Heyder et al., “Apoptotic-cell-derived membrane vesicles induce an alternative maturation of human dendritic cells which is disturbed in SLE,” Journal of Autoimmunity, vol. 40, no. 1, pp. 86–95, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. L. Abeler-Dörner, C. C. Rieger, B. Berger et al., “Interferon-α abrogates the suppressive effect of apoptotic cells on dendritic cells in an in vitro model of systemic lupus erythematosus pathogenesis,” The Journal of Rheumatology, vol. 40, no. 10, pp. 1683–1696, 2013. View at Publisher · View at Google Scholar · View at Scopus
  121. M. Yamauchi, M. Hashimoto, K. Ichiyama et al., “Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/ W F1 mice, is a positive regulator for NF-κB activation in dendritic cells,” International Immunology, vol. 19, no. 8, pp. 935–942, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. X. Huang, N. Shen, C. Bao, Y. Gu, L. Wu, and S. Chen, “Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cells,” Arthritis Research & Therapy, vol. 10, no. 4, article R91, 2008. View at Publisher · View at Google Scholar · View at Scopus
  123. Y. Hu and L. B. Ivashkiv, “Costimulation of chemokine receptor signaling by matrix metalloproteinase-9 mediates enhanced migration of IFN-α dendritic cells,” The Journal of Immunology, vol. 176, no. 10, pp. 6022–6033, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. A. J. Mangini, R. Lafyatis, and J. M. Van Seventer, “Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus,” Annals of the New York Academy of Sciences, vol. 1108, pp. 11–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Clement, N. Charles, B. Escoubet et al., “CD4+CXCR3+ T cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus,” Journal of Autoimmunity, vol. 63, pp. 59–67, 2015. View at Publisher · View at Google Scholar
  126. J. H. Wang, Q. Wu, P. Yang et al., “Type I interferon-dependent CD86high marginal zone precursor B cells are potent T cell costimulators in mice,” Arthritis & Rheumatism, vol. 63, no. 4, pp. 1054–1064, 2011. View at Publisher · View at Google Scholar · View at Scopus
  127. H. Li, Y. X. Fu, Q. Wu et al., “Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus,” The Journal of Clinical Investigation, vol. 125, no. 7, pp. 2877–2890, 2015. View at Publisher · View at Google Scholar
  128. T. E. Quan, R. M. Roman, B. J. Rudenga, V. M. Holers, and J. E. Craft, “Epstein-barr virus promotes interferon-α production by plasmacytoid dendritic cells,” Arthritis and Rheumatism, vol. 62, no. 6, pp. 1693–1701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. U. Båve, M. Magnusson, M.-L. Eloranta, A. Perers, G. V. Alm, and L. Rönnblom, “FcγRIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG,” The Journal of Immunology, vol. 171, no. 6, pp. 3296–3302, 2003. View at Publisher · View at Google Scholar · View at Scopus
  130. T. K. Means, E. Latz, F. Hayashi, M. R. Murali, D. T. Golenbock, and A. D. Luster, “Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9,” The Journal of Clinical Investigation, vol. 115, no. 2, pp. 407–417, 2005. View at Publisher · View at Google Scholar · View at Scopus
  131. J. Vollmer, S. Tluk, C. Schmitz et al., “Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8,” The Journal of Experimental Medicine, vol. 202, no. 11, pp. 1575–1585, 2005. View at Publisher · View at Google Scholar · View at Scopus
  132. C. Mold and T. W. D. Clos, “C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexes,” Arthritis and Rheumatism, vol. 65, no. 7, pp. 1891–1901, 2013. View at Publisher · View at Google Scholar · View at Scopus
  133. H. Wang, T. Li, S. Chen, Y. Gu, and S. Ye, “Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin,” Arthritis & Rheumatology, vol. 67, no. 12, pp. 3190–3200, 2015. View at Publisher · View at Google Scholar
  134. R. Lande, J. Gregorio, V. Facchinetti et al., “Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide,” Nature, vol. 449, no. 7162, pp. 564–569, 2007. View at Publisher · View at Google Scholar · View at Scopus
  135. R. Lande, D. Ganguly, V. Facchinetti et al., “Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus,” Science Translational Medicine, vol. 3, no. 73, Article ID 73ra19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  136. R. Baccala, R. Gonzalez-Quintial, A. L. Blasius et al., “Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 8, pp. 2940–2945, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. A. Sadanaga, H. Nakashima, M. Akahoshi et al., “Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice,” Arthritis and Rheumatism, vol. 56, no. 5, pp. 1618–1628, 2007. View at Publisher · View at Google Scholar · View at Scopus
  138. Y. Xu, P. Y. Lee, Y. Li et al., “Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus,” Journal of Immunology, vol. 188, no. 8, pp. 4113–4121, 2012. View at Publisher · View at Google Scholar · View at Scopus
  139. K. Yasuda, C. Richez, J. W. Maciaszek et al., “Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes Is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production,” The Journal of Immunology, vol. 178, no. 11, pp. 6876–6885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  140. E. Y. Chiang, X. Yu, and J. L. Grogan, “Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types,” The Journal of Immunology, vol. 186, no. 2, pp. 1279–1288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  141. H. Yanai, T. Ban, Z. Wang et al., “HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses,” Nature, vol. 462, no. 7269, pp. 99–103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. J. Tian, A. M. Avalos, S.-Y. Mao et al., “Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE,” Nature Immunology, vol. 8, no. 5, pp. 487–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  143. J. Di Domizio, S. Dorta-Estremera, M. Gagea et al., “Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 36, pp. 14550–14555, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. C. Orellana, A. Collado, M. V. Hernandez, J. Font, J. A. Del Olmo, and J. Munoz-Gomez, “When does amyloidosis complicate systemic lupus erythematosus?” Lupus, vol. 4, no. 5, pp. 415–417, 1995. View at Publisher · View at Google Scholar · View at Scopus
  145. S. Gaitonde, D. Samols, and I. Kushner, “C-reactive protein and systemic lupus erythematosus,” Arthritis Care and Research, vol. 59, no. 12, pp. 1814–1820, 2008. View at Publisher · View at Google Scholar · View at Scopus
  146. M. Kirschfink, F. Petry, K. Khirwadkar, R. Wigand, J. P. Kaltwasser, and M. Loos, “Complete functional C1q deficiency associated with systemic lupus erythematosus (SLE),” Clinical and Experimental Immunology, vol. 94, no. 2, pp. 267–272, 1993. View at Google Scholar · View at Scopus
  147. M. J. Walport, K. A. Davies, and M. Botto, “C1q and systemic lupus erythematosus,” Immunobiology, vol. 199, no. 2, pp. 265–285, 1998. View at Publisher · View at Google Scholar · View at Scopus
  148. C. Lood, B. Gullstrand, L. Truedsson et al., “C1q inhibits immune complex–induced interferon-α production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis,” Arthritis and Rheumatism, vol. 60, no. 10, pp. 3081–3090, 2009. View at Publisher · View at Google Scholar · View at Scopus
  149. M. Son, F. Santiago-Schwarz, Y. Al-Abed, and B. Diamond, “C1q limits dendritic cell differentiation and activation by engaging LAIR-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 46, pp. E3160–E3167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  150. B. Berghöfer, T. Frommer, G. Haley, L. Fink, G. Bein, and H. Hackstein, “TLR7 ligands induce higher IFN-α production in females,” Journal of Immunology, vol. 177, no. 4, pp. 2088–2096, 2006. View at Publisher · View at Google Scholar · View at Scopus
  151. X. Li, Y. Xu, L. Ma, L. Sun, G. Fu, and Y. Hou, “17beta-estradiol enhances the response of plasmacytoid dendritic cell to CpG,” PloS ONE, vol. 4, no. 12, Article ID e8412, 2009. View at Google Scholar · View at Scopus
  152. O. Berggren, N. Hagberg, G. Weber, G. V. Alm, L. Rönnblom, and M.-L. Eloranta, “B lymphocytes enhance interferon-α production by plasmacytoid dendritic cells,” Arthritis & Rheumatism, vol. 64, no. 10, pp. 3409–3419, 2012. View at Publisher · View at Google Scholar · View at Scopus
  153. P. Duffau, J. Seneschal, C. Nicco et al., “Platelet CD154 potentiates interferon-α secretion by plasmacytoid dendritic cells in systemic lupus erythematosus,” Science Translational Medicine, vol. 2, no. 47, Article ID 47ra63, 2010. View at Publisher · View at Google Scholar · View at Scopus
  154. N. Hagberg, O. Berggren, D. Leonard et al., “IFN-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK Cells via MIP-1β and LFA-1,” Journal of Immunology, vol. 186, no. 9, pp. 5085–5094, 2011. View at Publisher · View at Google Scholar · View at Scopus
  155. M.-L. Eloranta, T. Lovgren, D. Finke et al., “Regulation of the interferon-α production induced by RNA-containing immune complexes in plasmacytoid dendritic cells,” Arthritis & Rheumatism, vol. 60, no. 8, pp. 2418–2427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  156. D. M. Santer, B. E. Hall, T. C. George et al., “C1q deficiency leads to the defective suppression of IFN-α in response to nucleoprotein containing immune complexes,” The Journal of Immunology, vol. 185, no. 8, pp. 4738–4749, 2010. View at Publisher · View at Google Scholar · View at Scopus
  157. B. Cederblad, S. Blomberg, H. Vallin, A. Perers, G. V. Alm, and L. Rönnblom, “Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-α-producing cells,” Journal of Autoimmunity, vol. 11, no. 5, pp. 465–470, 1998. View at Publisher · View at Google Scholar · View at Scopus
  158. K. Sacre, L. A. Criswell, and J. M. McCune, “Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus,” Arthritis Research & Therapy, vol. 14, no. 3, article R155, 2012. View at Publisher · View at Google Scholar · View at Scopus
  159. S.-K. Kwok, J.-Y. Lee, S.-H. Park et al., “Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus,” Arthritis Research & Therapy, vol. 10, no. 2, article R29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  160. D. Fabricius, M. Neubauer, B. Mandel et al., “Prostaglandin E2 inhibits IFN-α secretion and Th1 costimulation by human plasmacytoid dendritic cells via E-prostanoid 2 and E-prostanoid 4 receptor engagement,” The Journal of Immunology, vol. 184, no. 2, pp. 677–684, 2010. View at Publisher · View at Google Scholar · View at Scopus
  161. D. Lindau, J. Mussard, A. Rabsteyn et al., “TLR9 independent interferon alpha production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoantigen,” Annals of the Rheumatic Diseases, vol. 73, no. 12, pp. 2199–2207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  162. M. F. Denny, S. Yalavarthi, W. Zhao et al., “A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs,” The Journal of Immunology, vol. 185, no. 6, p. 3779, 2010. View at Publisher · View at Google Scholar · View at Scopus
  163. A. Palanichamy, J. W. Bauer, S. Yalavarthi et al., “Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus,” Journal of Immunology, vol. 192, no. 3, pp. 906–918, 2014. View at Publisher · View at Google Scholar · View at Scopus
  164. G. McDonald, N. Cabal, A. Vannier et al., “Female bias in systemic lupus erythematosus is associated with the differential expression of X-linked Toll-like receptor 8,” Frontiers in Immunology, vol. 6, article 457, 2015. View at Publisher · View at Google Scholar
  165. C. Richez, K. Yasuda, A. A. Watkins et al., “TLR4 ligands induce IFN-α production by mouse conventional dendritic cells and human monocytes after IFN-β priming,” The Journal of Immunology, vol. 182, no. 2, pp. 820–828, 2009. View at Publisher · View at Google Scholar · View at Scopus
  166. T. Lövgren, M.-L. Eloranta, B. Kastner, M. Wahren-Herlenius, G. V. Alm, and L. Rönnblom, “Induction of interferon-α by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome auto antigen—associated RNA,” Arthritis and Rheumatism, vol. 54, no. 6, pp. 1917–1927, 2006. View at Publisher · View at Google Scholar · View at Scopus
  167. P. Y. Lee, J. S. Weinstein, D. C. Nacionales et al., “A novel type I IFN-producing cell subset in murine lupus,” The Journal of Immunology, vol. 180, no. 7, pp. 5101–5108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  168. J. Klarquist, C. M. Hennies, M. A. Lehn, R. A. Reboulet, S. Feau, and E. M. Janssen, “STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells,” The Journal of Immunology, vol. 193, no. 12, pp. 6124–6134, 2014. View at Publisher · View at Google Scholar · View at Scopus
  169. A. E. Wiedeman, D. M. Santer, W. Yan, S. Miescher, F. Käsermann, and K. B. Elkon, “Contrasting mechanisms of interferon-α inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists,” Arthritis & Rheumatism, vol. 65, no. 10, pp. 2713–2723, 2013. View at Publisher · View at Google Scholar · View at Scopus
  170. C. Lood, M. Allhorn, R. Lood et al., “IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment?” Arthritis and Rheumatism, vol. 64, no. 8, pp. 2698–2706, 2012. View at Publisher · View at Google Scholar · View at Scopus
  171. P. Lenert, K. Yasuda, L. Busconi et al., “DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Faslpr/lpr mice in vivo,” Arthritis Research & Therapy, vol. 11, no. 3, article R79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  172. M. Hirai, N. Kadowaki, T. Kitawaki et al., “Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis,” Blood, vol. 117, no. 2, pp. 500–509, 2011. View at Publisher · View at Google Scholar · View at Scopus
  173. H. T. Ichikawa, T. Conley, T. Muchamuel et al., “Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells,” Arthritis and Rheumatism, vol. 64, no. 2, pp. 493–503, 2012. View at Publisher · View at Google Scholar · View at Scopus
  174. H. Amuro, T. Ito, R. Miyamoto et al., “Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production,” Arthritis and Rheumatism, vol. 62, no. 7, pp. 2073–2085, 2010. View at Publisher · View at Google Scholar · View at Scopus
  175. V. Salvi, D. Bosisio, S. Mitola, L. Andreoli, A. Tincani, and S. Sozzani, “Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells,” Immunobiology, vol. 215, no. 9-10, pp. 756–761, 2010. View at Publisher · View at Google Scholar · View at Scopus
  176. M. Petri, D. J. Wallace, A. Spindler et al., “Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study,” Arthritis & Rheumatism, vol. 65, no. 4, pp. 1011–1021, 2013. View at Publisher · View at Google Scholar · View at Scopus
  177. H.-K. Kang, M. Liu, and S. K. Datta, “Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells,” Journal of Immunology, vol. 178, no. 12, pp. 7849–7858, 2007. View at Publisher · View at Google Scholar · View at Scopus
  178. S. R. Christensen, J. Shupe, K. Nickerson, M. Kashgarian, R. Flavell, and M. J. Shlomchik, “Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus,” Immunity, vol. 25, no. 3, pp. 417–428, 2006. View at Publisher · View at Google Scholar · View at Scopus
  179. X. Wu and S. L. Peng, “Toll-like receptor 9 signaling protects against murine lupus,” Arthritis & Rheumatism, vol. 54, no. 1, pp. 336–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  180. M.-L. Santiago-Raber, I. Dunand-Sauthier, T. Wu et al., “Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice,” Journal of Autoimmunity, vol. 34, no. 4, pp. 339–348, 2010. View at Publisher · View at Google Scholar · View at Scopus
  181. K. M. Nickerson, J. L. Cullen, M. Kashgarian, and M. J. Shlomchik, “Exacerbated autoimmunity in the absence of TLR9 in MRL.Faslpr mice depends on Ifnar1,” Journal of Immunology, vol. 190, no. 8, pp. 3889–3894, 2013. View at Publisher · View at Google Scholar · View at Scopus